NPI: 1902862824 · HARRODSBURG, KY 40330 · Critical Access Hospital · NPI assigned 04/21/2006
Authorized official SNAPP, WILLIAM controls 20+ related entities in our dataset. Read more
| Authorized Official | SNAPP, WILLIAM (CFO) |
| NPI Enumeration Date | 04/21/2006 |
Other providers sharing the same authorized official: SNAPP, WILLIAM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,811 | $1.39M |
| 2019 | 28,667 | $1.71M |
| 2020 | 30,564 | $1.59M |
| 2021 | 50,785 | $2.17M |
| 2022 | 52,615 | $2.41M |
| 2023 | 44,245 | $2.53M |
| 2024 | 34,100 | $2.03M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 74177 | 1,352 | 1,236 | $1.70M | |
| 99284 | 7,393 | 6,631 | $1.29M | |
| 99285 | 4,737 | 4,024 | $1.23M | |
| 99283 | 10,037 | 9,050 | $846K | |
| 80053 | 27,445 | 20,832 | $793K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12,220 | 11,049 | $528K |
| 84443 | 10,145 | 9,661 | $472K | |
| 87633 | 1,239 | 1,157 | $386K | |
| 97110 | 4,227 | 1,092 | $378K | |
| 70450 | 928 | 819 | $377K | |
| 80061 | 8,865 | 8,426 | $339K | |
| 85025 | 18,174 | 16,060 | $302K | |
| 96375 | 3,256 | 2,733 | $286K | |
| 74176 | 272 | 242 | $280K | |
| 0241U | 2,436 | 2,194 | $232K | |
| 96374 | 4,159 | 3,579 | $231K | |
| 71045 | 2,842 | 2,526 | $202K | |
| 93005 | 3,490 | 3,011 | $201K | |
| 82306 | 4,216 | 2,744 | $167K | |
| 71046 | 1,955 | 1,762 | $161K | |
| 84439 | 5,212 | 4,844 | $149K | |
| 87631 | 1,216 | 1,068 | $141K | |
| 96361 | 3,713 | 2,386 | $136K | |
| 99282 | 2,243 | 2,011 | $133K | |
| 84484 | 2,868 | 2,122 | $126K | |
| 96365 | 1,311 | 892 | $125K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 10,270 | 9,370 | $123K |
| 87635 | 3,139 | 2,981 | $121K | |
| 80307 | 1,831 | 1,645 | $114K | |
| 83036 | 4,545 | 4,317 | $111K | |
| 87798 | 4,700 | 2,158 | $110K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,589 | 1,370 | $107K |
| 99211 | 1,959 | 1,210 | $100K | |
| 36415 | 13,631 | 7,480 | $93K | |
| 87486 | 2,752 | 2,205 | $78K | |
| 82607 | 3,404 | 3,146 | $75K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12,807 | 10,081 | $71K |
| 87186 | 2,116 | 1,910 | $69K | |
| 87086 | 3,763 | 3,409 | $66K | |
| 87077 | 2,875 | 2,099 | $65K | |
| 81001 | 4,796 | 4,282 | $63K | |
| 87581 | 2,362 | 2,134 | $62K | |
| 80306 | 1,017 | 901 | $55K | |
| 73630 | 865 | 787 | $52K | |
| 80048 | 3,023 | 2,252 | $48K | |
| 83690 | 2,470 | 2,213 | $47K | |
| 87491 | 870 | 776 | $46K | |
| 96372 | 2,503 | 1,987 | $43K | |
| 87591 | 818 | 766 | $40K | |
| 83605 | 896 | 776 | $38K | |
| 84703 | 1,993 | 1,839 | $37K | |
| 82728 | 1,655 | 1,554 | $37K | |
| 83540 | 1,679 | 1,583 | $35K | |
| 82043 | 1,950 | 949 | $31K | |
| 73610 | 457 | 424 | $29K | |
| 73560 | 428 | 360 | $29K | |
| 87651 | 973 | 914 | $29K | |
| 94640 | 758 | 616 | $29K | |
| 84153 | 1,129 | 1,097 | $28K | |
| 85027 | 3,557 | 3,335 | $27K | |
| 87661 | 773 | 707 | $27K | |
| 83550 | 1,434 | 1,377 | $26K | |
| 87070 | 1,170 | 1,019 | $26K | |
| 80074 | 432 | 308 | $24K | |
| 83880 | 475 | 408 | $23K | |
| 73130 | 272 | 251 | $19K | |
| 11042 | 130 | 93 | $19K | |
| 96360 | 168 | 151 | $18K | |
| 85379 | 342 | 324 | $17K | |
| 85610 | 1,417 | 1,130 | $17K | |
| 86140 | 1,072 | 941 | $17K | |
| 87502 | 293 | 257 | $16K | |
| 83735 | 871 | 795 | $15K | |
| 84481 | 471 | 453 | $14K | |
| 69436 | 13 | 13 | $12K | |
| 77067 | 107 | 105 | $12K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 713 | 618 | $11K |
| 97162 | 116 | 109 | $10K | |
| 76705 | 44 | 38 | $9K | |
| 86038 | 529 | 467 | $9K | |
| 99212 | 161 | 127 | $8K | |
| 85652 | 835 | 783 | $8K | |
| 93306 | 14 | 13 | $8K | |
| 72148 | 13 | 12 | $7K | |
| 84145 | 140 | 123 | $7K | |
| 73030 | 115 | 100 | $6K | |
| 80050 | 222 | 170 | $6K | |
| 87430 | 330 | 301 | $6K | |
| J3490 | Unclassified drugs | 888 | 432 | $6K |
| 86703 | 123 | 117 | $6K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 509 | 313 | $6K |
| 97014 | 171 | 56 | $5K | |
| 82570 | 760 | 721 | $5K | |
| 87400 | 341 | 275 | $5K | |
| 87205 | 401 | 345 | $5K | |
| 73110 | 73 | 66 | $4K | |
| 82150 | 189 | 169 | $4K | |
| 85730 | 298 | 272 | $4K | |
| 87804 | 259 | 200 | $3K | |
| 00126 | 14 | 14 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 241 | 215 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 140 | 81 | $3K |
| 87040 | 125 | 79 | $3K | |
| 99213 | 203 | 189 | $3K | |
| 94760 | 361 | 269 | $3K | |
| 11043 | 22 | 14 | $2K | |
| 86431 | 160 | 152 | $2K | |
| 96376 | 66 | 28 | $2K | |
| 84480 | 128 | 124 | $2K | |
| 84403 | 57 | 53 | $2K | |
| 82550 | 102 | 83 | $1K | |
| 77063 | 63 | 56 | $1K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 507 | 277 | $1K |
| 12001 | 12 | 12 | $1K | |
| 82553 | 78 | 61 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 216 | 173 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 73 | 65 | $1K |
| 17250 | 14 | 12 | $1K | |
| 82746 | 42 | 38 | $1K | |
| 87880 | 103 | 98 | $917.13 | |
| L8699 | Prosthetic implant, not otherwise specified | 13 | 13 | $884.26 |
| 72100 | 13 | 12 | $860.88 | |
| 99214 | 81 | 76 | $854.47 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | 12 | $771.42 |
| 80320 | 13 | 13 | $684.11 | |
| 86677 | 14 | 14 | $643.05 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 74 | 42 | $639.37 |
| 82077 | 26 | 25 | $625.27 | |
| 96366 | 14 | 13 | $616.85 | |
| 87081 | 48 | 37 | $496.74 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 59 | 52 | $484.88 |
| 85007 | 96 | 86 | $458.05 | |
| 94664 | 130 | 101 | $430.36 | |
| 82962 | 67 | 53 | $254.60 | |
| 82803 | 17 | 13 | $247.89 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 36 | 30 | $211.81 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 36 | 26 | $184.87 |
| 85651 | 17 | 15 | $183.87 | |
| 36600 | 17 | 12 | $56.70 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 12 | 12 | $46.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 17 | 12 | $44.89 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 18 | 13 | $39.20 |
| 81015 | 14 | 14 | $3.05 |